logo
Astronauts for Crew-11 fly into KSC ahead of upcoming launch

Astronauts for Crew-11 fly into KSC ahead of upcoming launch

Yahoo6 hours ago
KENNEDY SPACE CENTER — The business of hurtling humans into space is getting routine on the Space Coast with the fourth flight of a SpaceX Crew Dragon queued up for this week. The crew going for that ride arrived in Florida on Saturday.
NASA astronauts Zena Cardman and Mike Fincke, JAXA (Japan Aerospace Exploration Agency) astronaut Kimiya Yui and Roscosmos cosmonaut Oleg Platonov, the quartet for SpaceX's Crew-11 mission to the International Space Station, flew into the former space shuttle landing site at KSC after noon under the searing sun as temperatures on the tarmac climbed into the 90s.
'Sorry for the heat, but it's Florida in the summertime,' said veteran Fincke, who kept cracking jokes and even made bunny ears behind Platonov's head during a photo as the crewmates talked to media.
They're slated to lift off as early as 12:09 p.m. Thursday from KSC's Launch Pad 39-A atop a Falcon 9 rocket riding in the Crew Dragon Endeavour.
'We've been training together for over a year now and we are ready to fly,' said Cardman, who is making her first spaceflight. 'As a first-time flyer, this is the first moment when it's really starting to feel real.'
They expect at least a six-month stay on board the space station where they will relieve the four members of Crew-10 on board since March.
In addition to the two NASA flights this year, SpaceX has flown a private polar orbital mission Fram2 in March and the private Axiom Space Ax-4 mission to the space station last month.
The launch is one shy of the five human spaceflight missions from Florida seen in 2024, although it would equal the number of people launching with 16 in space. Both last year's Boeing Starliner CFT mission and the Crew-9 mission only flew up with two crew each instead of four. That was because Crew-9 became the ride home for Starliner astronauts after NASA opted to send Boeing's beleaguered spacecraft home minus crew over safety concerns — and they ultimately had to be ferried home by SpaceX.
NASA astronaut Michael Fincke talks about how he started to bald after going to space causing laughter from Crew-11 crewmate and JAXA astronaut Kimiya Yui after they arrived to Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. (Richard Tribou/Orlando Sentinel) NASA astronaut and pilot Michael Fincke gives a handoff wave to Crew-11 crewmate JAXA astronaut Kimiya Yu as NASA astronaut and commander Zena Cardman, left, and Roscosmos cosmonaut Oleg Platonov, right, look on after they arrived to Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. (Richard Tribou/Orlando Sentinel) NASA astronaut and pilot Michael Fincke cracks a joke causing JAXA astronaut Kimiya Yui to break into laughter after they and their fellow Crew-11 crewmates, NASA astronaut and commander Zena Cardman and Roscosmos cosmonaut Oleg Platonov, arrived to Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. (Richard Tribou/Orlando Sentinel) The four members of Crew-11 arrive to Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. From left to right are NASA astronaut and commander Zena Cardman, NASA astronaut and pilot Michael Fincke, JAXA astronaut Kimiya Yui and Roscosmos cosmonaut Oleg Platonov along with his translator. (Richard Tribou/Orlando Sentinel) The four members of Crew-11 arrive to Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. From left to right are NASA astronaut and commander Zena Cardman, NASA astronaut and pilot Michael Fincke, JAXA astronaut Kimiya Yui and Roscosmos cosmonaut Oleg Platonov along with his translator. (Richard Tribou/Orlando Sentinel) Show Caption1 of 6NASA astronaut Michael Fincke, right, raises some bunny ears behind the head Roscosmos cosmonaut Oleg Platonov while posing for photos with their Crew-11 crewmates, NASA astronaut Zena Cardman and JAXA astronaut Kimiya Yui, after arriving at Kennedy Space Center on Saturday, July 26, 2025 ahead of their planned launch this week to the International Space Station. (Richard Tribou/Orlando Sentinel)Expand
Endeavour is making a record sixth trip to space, the first of SpaceX's fleet of five Crew Dragons to hit that mark as NASA looks to stretch their utility beyond the original five flights for which they have been certified.
Cardman was originally tapped as commander for the Crew-9 mission, but as a rookie, she was bumped in favor of another member of that crew with flight experience. She is now back for Crew-11 as its commander.
She becomes the last of 12 NASA astronauts from the 2017 class known as The Turtles to make it space.
'In spaceflight, the journey is often nonlinear. It's just a privilege to be here with this crew, especially. I have the privilege of overlapping with one of my classmates, Jonny Kim, who's currently on board as a member of Expedition 73. I also have the privilege of flying with Kimiya Yui, whose patch has a turtle on it. And so that makes him an honorary turtle in my heart.'
Fincke was also reassigned from what was supposed to be Starliner's first operational crew mission, Starliner-1, but shifted to this SpaceX mission as Boeing and NASA continue to work on Starliner's issues. He is making his fourth trip to space having made trips on Soyuz in 2004 and 2008 as well as the penultimate flight of the Space Shuttle Program, STS-134, on Space Shuttle Endeavour in 2011.
'It's been a really interesting journey watching brand new spaceships be built,' Fincke said. 'I'm very proud of our teams, both SpaceX and Boeing, to what they built together and really proud to actually finally fly on a commercial crew spacecraft.'
Japan's Yui also was training for a Starliner flight, but is now headed for his second trip to space — having been on a Soyuz mission in 2015.
'My last mission was 10 years ago, so I'm very much looking forward to going back to my home,' he said.
Platonov joins Cardman as the second rookie on this mission.
The four will be on board when the station reaches a milestone on Nov. 2, which will signify 25 years of continuous occupation. They will be part of Expeditions 73 and 74 along with the three members on board that flew up on a Soyuz.
'I'm personally looking forward to going back up to the space station. I helped build it, and now I get to see it in its full maturity with six other crewmates,' Fincke said.
NASA looks to decommission the station after 2030.
'I know it's coming near its time, but this is something that I think that humans should just really remember of all the cool things we can do when we work together constructively,' Fincke said.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ATAI Life Sciences (ATAI) Stock Plunge on Trial Failure News
ATAI Life Sciences (ATAI) Stock Plunge on Trial Failure News

Yahoo

time26 minutes ago

  • Yahoo

ATAI Life Sciences (ATAI) Stock Plunge on Trial Failure News

July 28 - Atai Life Sciences (NASDAQ:ATAI) shares slid 9% in pre?market trading on Monday after Recognify Life Sciences, an Atai?backed company, reported its Phase 2b trial of inidascamine for cognitive impairment linked to schizophrenia missed its primary endpoint. Warning! GuruFocus has detected 6 Warning Signs with ATAI. The oral compound, engineered to modulate multiple neurotransmitter pathways for pro?cognitive effects, failed to outperform placebo on key cognitive measures. Recognify said the results fell short of statistical significance. Atai's CEO acknowledged the setback but highlighted inidascamine's potential in CIAS and other indications. He added that Atai will redirect its efforts toward its wholly?owned psychedelic programs focused on affective disorders. Investors have been closely watching Atai's broader pipeline, which includes compounds targeting depression, PTSD and Alzheimer's disease. This latest trial disappointment adds to a string of mid?stage readouts that have tested market sentiment around biotech firms pivoting to next?generation neuroscience therapies. Despite today's drop, Atai's management reiterated its commitment to advancing its lead psychedelic candidates through upcoming Phase 1 and Phase 2 trials. Based on the one year price targets offered by 6 analysts, the average target price for ATAI Life Sciences NV is $9.83 with a high estimate of $12.00 and a low estimate of $7.00. The average target implies a upside of +175.44% from the current price of $3.57. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Citizen Scientists Are Accelerating Ecology Research, Study Suggests
Citizen Scientists Are Accelerating Ecology Research, Study Suggests

New York Times

time28 minutes ago

  • New York Times

Citizen Scientists Are Accelerating Ecology Research, Study Suggests

In the spring of 2019, a nature photographer hiking in the mountains of northern China snapped an image of an unusual insect: a fly that appeared to be disguised as a bumblebee, down to its fuzzy black-and-yellow stripes. The photographer uploaded the image to iNaturalist, a citizen science platform, where it attracted the attention of an entomologist. The following year, the entomologist published a paper describing the bumblebee mimic as a new species, now known as the mountain ghost stiletto fly. It's a testament to the power of citizen science — and it's not an isolated occurrence, according to a new study, which documents how scientists are harnessing iNaturalist data. Since iNaturalist was founded in 2008, observations submitted to the platform have been incorporated into more than 5,000 peer-reviewed papers, with references exploding in recent years, the scientists found. More than 1,400 such articles were published in 2022 alone — 10 times as many as just five years earlier and a publication rate of nearly four studies per day. The data has helped scientists identify new species, track the spread of invasive organisms, pinpoint critical habitats, predict the effects of climate change and explore animal behavior, among other things. 'iNaturalist is really pervasive throughout the biodiversity research,' said Corey Callaghan, an ecologist at the University of Florida and an author of the paper, which was published in BioScience on Monday. 'It is fundamentally shaping the way that scientists think about research and think about designing studies and think about answering questions about biodiversity.' iNaturalist users submit photos or audio recordings of the plants and animals they observe, along with the date, time and location. Anyone in the iNaturalist community can suggest an identification for the organism in the observation. If two-thirds of these suggestions agree, and the submission passes the platform's data quality review, the observation is classified as 'research grade,' and sent to a global biodiversity database available to scientists. Want all of The Times? Subscribe.

OpenEvidence's Meteoric Rise Is Huge For Doctors
OpenEvidence's Meteoric Rise Is Huge For Doctors

Forbes

time28 minutes ago

  • Forbes

OpenEvidence's Meteoric Rise Is Huge For Doctors

Medical research and science has never been easier to access. OpenEvidence has raised hundreds of millions of dollars. In its most recent funding round, it raised a $210 million Series B from prominent investors such as Google Ventures and Kleiner Perkins, bringing the company's valuation to nearly $3.5 billion. The company's goal is straightforward and incredibly ambitious: to collate the entire corpus of medical knowledge and research developments in a way that is easily accessible to physicians and thereby, improve health outcomes. The service is aiming to provide a similar 'touch and feel' as other generative AI services such as Chat GPT or Google's Gemini—except, its target audience is primarily doctors. Medical science is a rapidly evolving field with a perpetually expanding sea of knowledge, especially as research and development across the fields of disease, therapeutics and human sciences continue to grow. In fact, as Sequoia Capital notes, 'a new PubMed article [which is often the flagship resource for peer-reviewed science studies]The value of this type of technology is increasingly being recognized. The latest models for OpenAI's ChatGPT (GPT 4.1 and o3) have displayed incredible efficacy in taking command of medical knowledge; in May, the company published its work with HealthBench, proposing a rubric for model performance in healthcare and also indicating that GPT's latest models performed at par or even better than standard physician evaluations. Even Google's Gemini family of models has made significant progress in this space; its MedLM suite, for example, is a highly tuned model that can aid the entire healthcare workflow, ranging from answering medical questions to deciphering unstructured health data. Why is all of this important? There are a few different reasons. First and foremost, this technology is aiming to democratize medical knowledge in a way that is easy to access. Furthermore, it comes at a time when the healthcare system, and its respective workforce, is facing unprecedented headwinds. Studies have repeatedly indicated that physician burnout and attrition are incredibly concerning problems for health systems and organizations of all sizes; physicians simply do not have the bandwidth to fulfill all of their patient care duties in addition to the increasingly prevalent administrative, compliance and regulatory burdens placed on them. This also means that there is less time for professional development and continuing education. These technologies can serve as a major advantage to the physician workflow as they provide an opportunity to easily query, fact-check and understand the latest science that is involved with a condition. Carry this even further with tools such as OpenEvidence DeepConsult, which gives physicians access to PhD-level AI agents that can conduct medical research, or Gemini's foundation models that can rapidly decipher medical images, or even AI scribing technology that can rapidly generate patient-physician encounter notes, and soon, hours can be saved from a physician's daily workflow. This translates not only to millions of dollars saved annually in system costs, but also to more time available to spend with patients, improved access to care, and ultimately, increased efficacy and quality of care provided.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store